Shilajit and Joint Pain: What the Evidence Actually Shows No human trial found
Joint pain and mobility come up often in shilajit marketing, usually framed around minerals and anti-inflammatory properties. Here is what we could actually verify.
Key takeaways
- No human clinical trial tests shilajit for joint pain, arthritis, or mobility outcomes.
- Lab and animal research shows some antioxidant and anti-inflammatory activity, a much earlier stage of evidence.
- Persistent joint pain is worth discussing with a healthcare professional rather than addressing with a supplement.
What the research actually covers
We found laboratory and animal research suggesting some antioxidant and anti-inflammatory activity from compounds in shilajit, which is a real and published finding. We did not find a human clinical trial testing shilajit specifically for joint pain, arthritis, or mobility outcomes. That is a meaningful gap between the laboratory finding and the marketing claim built on top of it. See our evidence review for how we grade this kind of research generally.
What this means if you are considering it for joint pain
Persistent joint pain is worth discussing with a healthcare professional, particularly to rule out or manage an underlying condition, rather than relying on a supplement with laboratory level evidence rather than clinical evidence for this specific use. We are not presenting shilajit as a treatment for arthritis, joint disease, or chronic pain, and would be cautious of anyone who does.
FAQ
Does shilajit help with joint pain or arthritis?
We found no human clinical trial testing this. Laboratory research on anti-inflammatory compounds exists, but that is a different and much earlier stage of evidence than a demonstrated effect on joint pain in people.
Is it safe to use for mobility support alongside other treatment?
Speak with your healthcare professional before adding any supplement if you are managing a joint condition or taking medication for it.
